Cargando…
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains
Facing the imminent need for vaccine candidates with cross-protection against globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants, we present a conserved antigenic peptide RBD9.1 with both T-cell and B-cell epitopes. RBD9.1 can be recognized by coronavirus disea...
Autores principales: | Gao, Fengxia, Huang, Jingjing, Li, Tingting, Hu, Chao, Shen, Meiying, Mu, Song, Luo, Feiyang, Song, Shuyi, Hao, Yanan, Wang, Wang, Han, Xiaojian, Qian, Chen, Wang, Yingming, Wu, Ruixin, Li, Luo, Li, Shenglong, Jin, Aishun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688401/ https://www.ncbi.nlm.nih.gov/pubmed/34950151 http://dx.doi.org/10.3389/fimmu.2021.789905 |
Ejemplares similares
-
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
por: Mu, Song, et al.
Publicado: (2022) -
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding
por: Long, Yingyi, et al.
Publicado: (2021) -
T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients
por: Li, Luo, et al.
Publicado: (2021) -
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021) -
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
por: Han, Xiaojian, et al.
Publicado: (2021)